Search results
Found 20333 matches for
On 24-25 Jan 2019, investigators met in Bangkok to launch the Developing Triple Artemisinin-based Combination Therapies (DeTACT) Project. Led by MORU and funded by UKaid and the UK Department for International Development (DfID), DeTACT is a large, 14 site trial in 8 African and 5 Asian countries that will study the efficacy, safety and tolerability of two Triple Artemisinin Combination Therapy (TACT) combinations, using combinations of existing antimalarial drugs.
Direk Limmathurotsakul
Research Scientists
Direk Limmathurotsakul - Professor of Infectious Disease Epidemiology
Susanna Dunachie
Principal Investigators Research Scientists
Susanna Dunachie - Professor of Infectious Diseases
Trudie Lang
Principal Investigators Research Scientists
Trudie Lang - Professor of Global Health Research
Paul Newton
Principal Investigators Research Scientists
Paul Newton - Professor of Tropical Medicine
Thuong Thuong Nguyen
Principal Investigators Research Scientists
Thuong Thuong Nguyen - Associate Professor
Wirichada Pan-ngum
MSc IHTM Lecturers MSc MGH Lecturers Research Scientists
Wirichada Pan-ngum - Associate Professor
Anthony Scott
Principal Investigators Research Scientists
Anthony Scott - Visiting Professor of Vaccinology
Joel Tarning
MSc MGH Lecturers Principal Investigators Research Scientists
Joel Tarning - Professor of Clinical Pharmacology
Chris Paton
Principal Investigators Research Scientists
Chris Paton - Head of the Global Health Informatics Group
Brian Angus
MSc IHTM Lecturers MSc IHTM steering committee Principal Investigators Research Scientists
BSc, MBChB, DTM&H, FRCP, MD, FFTM Brian Angus - Professor and Reader in Infectious Diseases